DOCK1 and central nervous system cancer: It specifically blocks the interaction site of RAC1 with its GEFs, particularly RAC1-TIAM1 and RAC1-DOCK180, and it was reported to induce apoptosis and inhibit proliferation and migration in LN229 and U-87 glioma cell lines [13].